Skip to search formSkip to main contentSkip to account menu

BP-100-1.01

Known as: BP-1001, BP1001 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Interim Safety and Efficacy of Lower Intensity Induction Therapy with Intravenous Prexigebersen (BP1001) in Patients with Untreated Acute Myeloid Leukemia (AML)
Background: The growth factor receptor bound protein-2 (Grb2) is vital to tumor progression. Prexigebersen (BP1001) is a… 
2016
2016
BP1001, a Novel Therapeutic for Chronic Myelogenous Leukemia
Background: The Growth factor receptor bound protein-2 (Grb2) is essential to cancer cell signaling. Grb2 binds to numerous… 
1994
1994
[Arterial blood pressure measurement with oscillometric instruments in newborns and infants].
Non-invasive blood pressure measurements by the auscultatory method do not provide reliable, reproducible blood pressure values… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)